Main Article Content


Background: The involvement of neuropsychiatry is reported in 6% to 91% of Systemic Lupus Erythematosus (SLE) patients. It can cause fatal morbidity and mortality. Memory impairment is one of the most common symptoms of neuropsychiatry involvement. This study aims to find out the performance of memory test in SLE patients using Indonesian version of Montreal Cognitive Assessment (MoCA-Ina).

Method: This cross sectional study recruited 30 SLE patients. Cognitive abilities and patient’s memory were examined using Indonesian version of Montreal Cognitive Assessment (MoCA-Ina). Cognitive impairment was determined when total MoCA-Ina score was below 26. For memory evaluation, immediate recall or delayed recall impairment was determined when the patient failed in each memory subtests.

Results: The mean of total MoCA-Ina score was 24.97 (SD±3.14). Fifty percent of the SLE patients had cognitive impairment, with the domain involved being delayed recall (86.67%), attention (60%), language (56.67%), abstraction (53.33%), and visuo-spatial/ executive function (36.67%). Most patients (86.67%) could completely repeat immediate recall. While
only 4 (13.33%) subjects could repeat delayed recall completely without any clue. Of the 26 SLE patients who failed to recall completely, 24 (92.3%) of them succeeded to recall completely after getting clue(s).

Conclusion: Memory impairment is the most frequent cognitive impairment in SLE patients, especially in delayed recall. By using the memory subtests of MoCAIna, more than four fifth of patients with SLE was detected having delayed recall memory impairment and almost all of them could recalled completely after getting clue(s). This findings indicated that the final
step of memory process retrieval in SLE was interrupted while being encoded, but retention pathway were stillintact.

Keywords: Systemic Lupus Erythematous, Memory, MoCA-Ina

Article Details

How to Cite
Anjalia, S., Ong, P. A., Atik, N., & Hamijoyo, L. (2018). Memory Performance in Patient with Systemic Lupus Erythematosus Using MoCA-Ina in Hasan Sadikin Genneral Hospital Bandung. Indonesian Journal of Rheumatology, 9(1).


  1. Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, et al. Neurocognitive dysfunction in systemic lupus erythematosus: Association with antiphospholipid antibodies, disease activity and chronic damage. PLoS One. 2012;7(3):e33824.
  2. West SG. Clinical aspects of the nervous system. In: Wallace D, Hahn BH, editors. Dubois’ lupus erythematosus and related syndromes. 8 ed. Philadelphia, PA: Elsevier Health Sciences; 2012. p 368-81.
  3. Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against nmda receptors mediate cognitive impairment. Proc Natl Acad Sci U S A. 2006;103(52):19854-9.
  4. Prasetyo BT, Lumempouw SF, Ramli Y, Herqutanto. Nilai normal montreal cognitive assesment versi indonesia (MoCA-Ina). 2011;29(1):14.
  5. Julayanont P, Phillips N, Chertkow H, Nasreddine ZS. Montreal cognitive assessment (moca): Concept and clinical review. In: Larner JA, editor. Cognitive screening instruments: A practical approach. London: Springer London; 2013. p. 111-51.
  6. Adhikari T, Piatti A, Luggen M. Cognitive dysfunction in sle: Development of a screening tool. Lupus. 2011;20(11):1142-6.
  7. Ortona E, Pierdominici M, Maselli A, Veroni C, Aloisi F, Shoenfeld Y. Sexbased differences in autoimmune diseases. Annali dell’Istituto Superiore di Sanità . 2016; 52(2): 205-12.
  8. Panopalis P, Julian L, Yazdany J, Gillis JZ, Trupin L, Hersh A, et al. Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Care & Research. 2007;57(8):1453-60.
  9. Utset TO, Baskaran A, Segal BM, Trupin L, Ogale S, Herberich E, et al. Work disability, lost productivity and associated risk factors in patients diagnosed with systemic lupus erythematosus. Lupus science & medicine. 2015;2(1):e000058.
  10. Appenzeller S, Cendes F, Costallat LT. Cognitive impairment and employment status in systemic lupus erythematosus: A prospective longitudinal study. Arthritis Rheum. 2009;61(5):680-7.
  11. Mahdavi Adeli A, Haghighi A, Malakouti SK. Prevalence of cognitive disorders in patients with systemic lupus erythromatosus; a crosssectional study in rasoul-e-akram hospital, tehran, iran. Arch Iran Med. 2016;19(4):257-61.
  12. Hawro T, Krupińska-Kun M, Rabe-Jabłońska J, Sysa-Jędrzejowska A, Robak E, Bogaczewicz J, et al. Psychiatric disorders in patients with systemic lupus erythematosus: Association of anxiety disorder with shorter disease duration. Rheumatol Int. 2011;31(10):1387-91.
  13. Kozora E, Arciniegas DB, Duggan E, West S, Brown MS, Filley CM. White matter abnormalities and working memory impairment in systemic lupus erythematosus. Cogn Behav Neurol. 2013;26(2):63-72.
  14. Brewer JB, Gabrieli JD, Preston AR, Vaidya CJ, Rosen AC. Memory. In: Goetz CG, editors. Textbook of clinical neurology. 3 ed. Chicago: Saunders Elsevier; 2007. p 63-78.
  15. Paran D, Litinsky I, Shapira-Lichter I, Navon S, Hendler T, Caspi D, et al. Impaired memory and learning abilities in patients with systemic lupus erythematosus as measured by the rey auditory verbal learning test. Ann Rheum Dis. 2009;68(6):812-6.
  16. de Melo LF, Da-Silva SL. Neuropsychological assessment of cognitive disorders in patients with fibromyalgia, rheumatoid arthritis, and systemic lupus erythematosus. Rev Bras Reumatol. 2012;52(2):181-8.
  17. Maneeton B, Maneeton N, Louthrenoo W. Cognitive deficit in patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2010;28(1):77-83.
  18. Shapira-Lichter I, Vakil E, Litinsky I, Oren N, Glikmann-Johnston Y, Caspi D, et al. Learning and memory-related brain activity dynamics are altered in systemic lupus erythematosus: A functional magnetic resonance imaging study. Lupus. 2013 ;22(6) :562-73.
  19. Shucard JL, Gaines JJ, Ambrus J, Jr., Shucard DW. C-reactive protein and cognitive deficits in systemic lupus erythematosus. Cogn Behav Neurol. 2007;20(1):31-7.